The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia

Research output: Contribution to journalArticlepeer-review


Ferroptosis is an iron-dependent cell death caused by impaired glutathione metabolism, lipid peroxidation and mitochondrial failure. Emerging evidences report a role for ferroptosis in Friedreich's Ataxia (FRDA), a neurodegenerative disease caused by the decreased expression of the mitochondrial protein frataxin. Nrf2 signalling is implicated in many molecular aspects of ferroptosis, by upstream regulating glutathione homeostasis, mitochondrial function and lipid metabolism. As Nrf2 is down-regulated in FRDA, targeting Nrf2-mediated ferroptosis in FRDA may be an attractive option to counteract neurodegeneration in such disease, thus paving the way to new therapeutic opportunities. In this study, we evaluated ferroptosis hallmarks in frataxin-silenced mouse myoblasts, in hearts of a frataxin Knockin/Knockout (KIKO) mouse model, in skin fibroblasts and blood of patients, particularly focusing on ferroptosis-driven gene expression, mitochondrial impairment and lipid peroxidation. The efficacy of Nrf2 inducers to neutralize ferroptosis has been also evaluated.

Original languageEnglish
Article number101791
JournalRedox Biology
Publication statusPublished - Nov 2020


  • EPI-743
  • Ferroptosis
  • Friedreich ataxia
  • Lipid peroxides
  • Mitochondria
  • Nrf2
  • Redox imbalance
  • Sulforaphane

ASJC Scopus subject areas

  • Organic Chemistry
  • Clinical Biochemistry


Dive into the research topics of 'The Nrf2 induction prevents ferroptosis in Friedreich's Ataxia'. Together they form a unique fingerprint.

Cite this